Improving personalized treatment with alpha particle radiation for cancer
Macro-to-micro (M2µ) Activity Apportionment for αRPT
This study is looking at a new way to improve cancer treatment with special radiation by measuring how it spreads in the body, so doctors can give each patient a more personalized and effective therapy while minimizing side effects.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10931448 on NIH RePORTER |
What this research studies
This research focuses on enhancing the delivery of alpha particle radiopharmaceuticals (αRPTs) for cancer treatment by developing a new dosimetric methodology called Macro-to-micro (M2µ). The goal is to create a more personalized approach to treatment by accurately measuring the distribution of radiation in specific organs and tissues, which can help tailor therapy to individual patients. By using murine models, the researchers will assess how radiation is absorbed in different organ regions, aiming to improve treatment outcomes and reduce side effects. This innovative approach seeks to address current limitations in dosimetry that affect the effectiveness and safety of αRPTs.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with bone metastases or other cancers that may benefit from alpha particle radiopharmaceutical therapies.
Not a fit: Patients who do not have cancers treatable with alpha particle radiation or those who are not eligible for radiopharmaceutical therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized cancer treatments with fewer side effects for patients receiving alpha particle radiation therapy.
How similar studies have performed: Other research has shown promise in the use of targeted alpha particle therapies, but the specific Macro-to-micro methodology is a novel approach that has not been extensively tested.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Hobbs, Robert Francois — Johns Hopkins University
- Study coordinator: Hobbs, Robert Francois
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.